G22V (p.Gly22Val) variant of CEBPE (Q15744)
G22V (p.Gly22Val) in CEBPE (Q15744) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.19 / 1. The record also includes structural context.
G22V (p.Gly22Val) variant details
- p.Gly22Val
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.185
- REVEL 0.14
- ESM-1b 0.00
- AlphaMissense 0.11
- MetaLR 0.11
- MetaSVM -1.00
- SIFT 0.17
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available